ANTINEOPLASTIC COMBINATIONS CONTAINING AND MTOR INHIBITOR AND AN ANTIMETABOLIC ANTINEOPLASTIC AGENT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

摘要

The invention provides the use of a combination of an mTOR inhibitor such as a rapamycin and an antimetabolite antineoplastic agent such as gemsitabine or fluorouracil in the treatment of neoplasms.